05/22/2026 | Press release | Distributed by Public on 05/22/2026 12:34
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The Company received approval from the Canadian Securities Exchange (the "CSE") to list its common shares (the "Common Shares") on the CSE. Trading of the Common Shares in the capital of the Company commenced on August 5, 2022, under the symbol "TWOH".
Cuore Food Services
Cuore Food Services is the Company's wholesale food distribution branch. Cuore Food Services uses inventory from the Company's warehouse as well as inventory it acquires on an ad hoc basis, and focuses on bulk delivery of goods to food service business such as restaurants, hotels, event planning/hosting businesses.
Management's Plan of Operation
In June 2025, the Company announced, after fully evaluating the legacy business, the Company is taking steps to reinvigorate it and establish a new pathway in the same business space. The Company will continue to evaluate opportunities both inside and outside the food industry, including, but not limited to, ventures within the fintech and gig economy spaces.
Critical Accounting Policies and Estimates
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the Financial Statements and accompanying notes. Estimates are used for, but not limited to, the accounting for the allowance for doubtful accounts, inventories, impairment of long-term assets, stock-based compensation, derivatives, income taxes and loss contingencies. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions.
We believe the following critical accounting policies, among others, may be impacted significantly by judgment, assumptions and estimates used in the preparation of the Financial Statements:
NET LOSS PER SHARE
Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding for the period increased to include the number of additional common shares that would have been outstanding if potentially dilutive securities had been issued. Dilutive net loss per share for common stock is calculated utilizing the if-converted method which assumes the conversion non-redeemable convertible notes and the line of credit. On March 31, 2026, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and convertible promissory notes of 1,826,425,205 shares as their effect would have been anti-dilutive. On March 31, 2025, we excluded the common stock issuable upon conversion of non-redeemable convertible notes and Series C Stock of 1,551,541,351 shares as their effect would have been anti-dilutive.
STOCK-BASED COMPENSATION
The Company accounts for stock incentive awards issued to employees and non-employees in accordance with ASC 718, Stock Compensation. Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.
DERIVATIVE LIABILITY
In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.
In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
The Company follows ASC Section 815-40-15 ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.
The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 815-10-25-1 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.
The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.
RECENT ACCOUNTING PRONOUNCEMENTS
In October 2023, the FASB issued ASU No. 2023-06, "Disclosure Improvements - Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative." The ASU amends the disclosure or presentation requirements related to various subtopics in the FASB ASC. The ASU was issued in response to the SEC's August 2018 final amendments in Release No. 33-10532, Disclosure Update and Simplification that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated. The guidance in ASU 2023-06 is intended to align GAAP requirements with those of the SEC and to facilitate the application of GAAP for all entities. The amendments introduced by ASU 2023-06 are effective if the SEC removes the related disclosure or presentation requirement from its existing regulations by June 30, 2027. If, by June 30, 2027, the SEC has not removed the applicable requirements from its existing regulations, the pending content of the associated amendment will be removed from the ASC and will not become effective for any entities. Early adoption is permitted. The adoption of ASU 2023-06 is not expected to have a material impact on the Company's consolidated financial statements or related disclosures.
ASU 2024-03, Disaggregation of Income Statement Expenses ("ASU 2024-03"), requires public companies to disaggregate key expense categories, such as inventory purchases, employee compensation and depreciation in their financial statements. This aims to improve investor insight into company performance. ASU 2024-03 was originally effective for fiscal years beginning after December 15, 2024, and interim periods within fiscal years beginning after December 15, 2025, with early adoption permitted. The Company is currently evaluating the impact, if any, adoption will have on its consolidated financial statements and disclosures.
ASU 2025-01, Income Statement - Expense Disaggregation Disclosures - Clarifying the Effective Date ("ASU 2025-01"), clarifies the effective date of ASU 2024-03. This amendment states that ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact, if any, adoption will have on its consolidated financial statements and disclosures.
ASU 2025-05, Financial Instruments-Credit Losses: Measurement of Credit Losses for Accounts Receivable and Contract Assets for Private Companies and Certain Not-for-profit Entities (PCC) ("ASU 2025-05"), updates accounting standards for revenue from contracts with customers (ASC 606). ASU 2025-05 permits an entity to assume that current conditions as of the balance sheet date will not change for the remaining life of the asset when estimated expected credit losses, and an accounting policy election to consider subsequent cash-collection activity after the balance sheet date. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted this new standard on January 1, 2026 and the adoption did not have a material impact on the consolidated financial statements.
Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.
COMPARISON OF RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2026 and 2025
Operating expenses:
| Three months ended March 31, | Change | |||||||||||||||
|
2026 $ |
2025 $ |
$ | % | |||||||||||||
| Salaries and benefits | 79,500 | 55,000 | 24,500 | 44 | ||||||||||||
| Occupancy expense | - | 1,254 | (1,254 | ) | (100 | ) | ||||||||||
| Advertising and travel | 1,134 | - | 1,134 | - | ||||||||||||
| Auto expenses | - | 340 | (340 | ) | (100 | ) | ||||||||||
| Consulting | 43,933 | 5,954 | 37,979 | 638 | ||||||||||||
| Depreciation and Amortization | 377 | 2,605 | (2,228 | ) | (86 | ) | ||||||||||
| Bad debt | - | 6,438 | (6,438 | ) | (100 | ) | ||||||||||
| Office and general expenses | 25,272 | 19,784 | 5,488 | 28 | ||||||||||||
| Professional fees | 85,470 | 165,694 | (80,224 | ) | (48 | ) | ||||||||||
| Freight and delivery | - | - | - | - | ||||||||||||
| Total operating expenses | 235,686 | 257,069 | (21,383 | ) | (8 | ) | ||||||||||
Our total operating expenses for the three months ended March 31, 2026 was $235,686, compared to $257,069, for the three months ended March 31, 2025, respectively. The decrease in total operating expense is primarily due to decrease in professional fees, offset by an increase in salaries and benefits.
Salaries and benefits for the three months ended March 31, 2026 and 2025, comprise primarily compensation of our officers and directors of $79,500 and $55,000, respectively.
During the three months ended March 31, 2026 and 2025, consulting expenses of $43,933 and $5,954 consisted of costs related to the development of new businesses and bookkeeping services.
Professional fees comprise legal fees from compliance and the review of proposed transactions and debt agreements, annual audit and filling fees.
Other income (expense):
| Three months ended March 31, | Change | |||||||||||||||
|
2026 $ |
2025 $ |
$ | % | |||||||||||||
| Amortization of debt discount and interest expense | (44,846 | ) | (73,363 | ) | 28,517 | (39 | ) | |||||||||
| Initial derivative expense | (33,804 | ) | - | (33,804 | ) | - | ||||||||||
| Change in fair value of derivative liability | 250,102 | - | 250,102 | - | ||||||||||||
| Total other income (expenses) | 171,452 | (73,363 | ) | 238,765 | (325 | ) | ||||||||||
Amortization of debt discount and interest expense for the three months ended March 31, 2026 was $44,846, compared to $73,363 for the three months ended March 31, 2025. Amortization of debt discount and interest expense relates to the issuance of non-redeemable convertible notes, convertible notes and promissory notes.
Initial derivative expense of $33,804 for the three months ended March 31, 2026 represents the difference between the fair value of the total embedded derivative liability of $113,804 and the cash received of $80,000 for convertible note issued on January 16, 2026.
During the three months ended March 31, 2026 and 2025, the gain due to the change in fair value of derivative liabilities was $250,102 and $0, respectively.
Net loss for the period:
| Three months ended March 31, | Change | |||||||||||||||
|
2026 $ |
2025 $ |
$ | % | |||||||||||||
| Net loss for the period | (64,234 | ) | (330,432 | ) | 260,148 | (79 | ) | |||||||||
Our net loss for the three months ended March 31, 2026 was $64,234, compared to $330,432 for the three months ended March 31, 2025, respectively. Our losses during the three months ended March 31, 2026 and 2025 are primarily due to costs associated with compensation to our officers and directors, professional fees, interest, offset by an decrease in fair value of derivative liabilities.
QUARTERLY RESULTS OF OPERATIONS
The following is a summary of selected quarterly information that has been derived from the financial statements of the Company. This summary should be read in conjunction with the consolidated financial statements of the Company.
| Quarter Ended | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | September 30, 2024 | June 30, 2024 |
| Sales | $- | $- | $- | $- | $- | $140,258 | $179,502 | $226,289 |
| Gross profit | $- | $- | $- | $- | $- | ($34,216) | $26,025 | $45,010 |
| Operating expenses | ($235,686) | ($332,678) | ($259,977) | ($207,602) | ($257,069) | ($299,791) | ($300,665) | ($311,499) |
| Other income (expense) | $171,452 | $930,910 | ($156,359) | ($128,716) | ($73,363) | ($489,659) | ($58,477) | ($228,552) |
| Net income (loss) for the period | ($64,234) | $598,232 | ($416,336) | ($336,318) | ($330,432) | ($823,666) | ($333,117) | ($495,041) |
| Basic and diluted net income (loss) per share | ($0.00) | ($0.00) | ($0.00) | ($0.00) | ($0.00) | ($0.00) | ($0.00) | ($0.00) |
LIQUIDITY AND CAPITAL RESOURCES
For the three months ended March 31, 2026
Cash flows used in operating activities
| Three months ended March 31, | Change | |||||||||||||||
|
2026 $ |
2025 $ |
$ | % | |||||||||||||
| Net cash used in operating activities | (173,641 | ) | (198,079 | ) | 24,438 | (12 | ) | |||||||||
Our net cash used in operating activities for the three months ended March 31, 2026 and 2025 is $173,641 and $198,079, respectively. Our net loss for the three months ended March 31, 2026 of $70,284 and change in fair value of derivative liabilities of $250,102 was the main contributing factors for our negative cash flow. We were able to partially offset the cash used in operating activities with non-cash expenses such as amortization of debt discount and initial derivative expense.
Cash flows used in investing activities
| Three months ended March 31, | Change | |||||||||||||||
|
2026 $ |
2025 $ |
$ | % | |||||||||||||
| Net cash used in investing activities | (321,887 | ) | - | (321,887 | ) | - | ||||||||||
Cash flows from financing activities
| Three months ended March 31, | Change | |||||||||||||||
|
2026 $ |
2025 $ |
$ | % | |||||||||||||
| Net cash used in financing activities | 315,000 | 199,098 | 115,902 | 58 | ||||||||||||
Our net cash provided by financing activities for the three months ended March 31, 2026 and 2025, is $315,000 and $199,098, respectively.
During the three months ended March 31, 2026 and 2025, the Company received cash advances from related party of $235,000 and $199,098, respectively. These cash advances earns interest at 8% per annum, is unsecured and is due on demand.
As of March 31, 2026, we had cash of $47,057, working capital (deficiency) of $(2,387,220) and total liabilities of $2,467,657.
Our working capital as of March 31, 2026 and December 31, 2025 is as follows:
|
March 31, 2026 |
December 31, 2025 |
|||||||
| Current assets | $ | 80,437 | $ | 254,236 | ||||
| Current liabilities | 2,467,657 | 2,264,701 | ||||||
| Working capital (Deficiency) | $ | (2,387,220 | ) | $ | (2,010,465 | ) | ||
The Company is continuing to focus improving cash flows from operations by reducing incentives to customers, by making purchases from different suppliers, accelerating the collection of accounts receivable, reducing expenses, managing accounts payable balances and by paying our officers, directors, consultants and staff with our stock.
The Company's financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. During the three months ended March 31, 2026, the Company incurred a net loss of $64,234 and used cash in operating activities of $173,641, and on March 31, 2026, had stockholders' deficit of $2,007,433 and an accumulated deficit of $95,069,236 These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued. The Company's independent registered public accounting firm, in their report on the Company's financial statements for the year ended December 31, 2025, contains an explanatory paragraph regarding the Company's ability to continue as a going concern. The Company's financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.
Over the next 12 months we expect to spend approximately $300,000 in cash for operations, legal, accounting and related services and to implement our business plan. We hope to be able to compensate our independent contractors with stock-based compensation, which will not require us to use our cash, although there can be no assurances that we will be successful in these efforts.
| Cash Required to Implement of Business Plan | ||||
| General and Administration | $ | 300,000 | ||
| Total Estimated Cash Expenditures | $ | 300,000 | ||
We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink.. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.
The inability to obtain financing or generate sufficient cash from operations could require us to reduce or eliminate expenditures for developing products and services, or otherwise curtail or discontinue our operations, which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, to the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to existing stockholders. If we raise additional funds through the issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of our common stock and the terms of such debt could impose restrictions on our operations. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may seek to compensate providers of services by issuing stock in lieu of cash, which may also result in dilution to existing stockholders.
Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol "TWOH".
Commitments for future capital expenditures at March 31, 2026 is as follows:
| Payments Due by Period | ||||||||||||||||||||
| Contractual obligations |
Total $ |
Less than 1 year $ |
1 - 3 years $ |
4 - 5 years $ |
After 5 years $ |
|||||||||||||||
| Accounts payable and accrued liabilities | 806,346 | 806,346 | - | - | - | |||||||||||||||
| Debt | 1,253,723 | 1,253,723 | - | - | - | |||||||||||||||
| Non-redeemable convertible notes | 125,918 | 125,918 | - | - | - | |||||||||||||||
| Convertible promissory note | 22,504 | 22,504 | ||||||||||||||||||
| Derivative liability | 259,166 | 259,166 | ||||||||||||||||||
| Operating leases | - | - | - | - | - | |||||||||||||||
| Total contractual obligations | 2,467,657 | 2,467,657 | - | - | - | |||||||||||||||
OPERATING CAPITAL AND CAPITAL EXPENDITURE REQUIREMENTS
We expect to be able to secure additional capital through advances from our Chief Executive Officer in order to pay expenses such as organizational costs, filing fees, accounting fees and legal fees, however, we do not have any written or oral agreements with any other third parties which require them to fund our operations. We are currently in discussions with investors for private loans and an equity line of credit. Although there can be no assurances that we will be able to obtain such funds in the future, the Company has been able to secure financing to continue operations since its inception on April 3, 2009. We are currently quoted on OTC Pink. If we need additional capital in the next twelve months and if we cannot raise such capital on acceptable terms, we may have to curtail our operations or terminate our business entirely.
Our common stock started trading over the counter and has been quoted on the Over-The Counter Bulletin Board since February 17, 2011. The stock currently trades under the symbol "TWOH".
RELATED PARTY TRANSACTIONS
Three months ended March 31, 2026 and 2025
Non-redeemable Convertible Notes - Related Party
On September 13, 2018, the Company entered into a Side Letter Agreement ("Original Note") with a non-related investor, Jordan Turk, to amend and add certain terms to unsecured, non-interest bearing, due on demand notes payable totaling $40,000 issued by the Company during the period of July 10, 2018 to September 13, 2018. The issue price of the Note is $40,000 with a face value of $48,000 and the Note has an original maturity date of December 31, 2018 which is subject to automatic annual renewal. On June 29, 2021, the Company and Jordan Turk entered into an Agreement to change the original maturity date of the Note to December 31, 2025. At the option of the Company, the Company may convert principal and interest at a fixed conversion price of $0.0001 per share of the Company's common stock. The Note allows the lender to secure a portion of the Company assets up to 200% of the face value of the Note. If the Note is not paid on December 31 each year, the outstanding face amount of the Note increases by 20% on January 1 the following year.
On December 30, 2024, Jordan Turk and the Company agreed to exchange $43,328 of principal and interest of Original Note for a New Promissory Note with a carrying value of $71,993 (see Note 7) resulting in a loss of extinguishment of $28,665.
Also, on December 30, 2024, Jordan Turk entered into an agreement to assign the remaining outstanding principal and interest of the Original Note with a carrying value of $100,000 to Emil Assentato, the Chief Executive Officer of the Company.
The consolidated statement of operations includes amortization of debt discount of $5,918 and $4,932 for the three months ended March 31, 2026 and 2025, respectively, due to the 20% increase in face value on January 1 each year. On March 31, 2026 and December 31, 2025, the carrying amount of the Note is $125,918 (face value of $144,000 less $18,082 unamortized discount) and $120,000 (face value of $120,000 less $0 unamortized discount), respectively.
Promissory Notes - Related Party
On March 31, 2026 and December 31, 2025, $1,136,654 (comprising of $1,088,100 of advances and $48,554 of interest) and $882,632 (comprising of $853,100 of advances and $29,532 of interest), respectively was due to Emil Assentato, the Company's Chief Executive. During three months ended March 31, 2026, the Company issued total advances for $235,000 comprising $235,000 for cash received and $0 of expenses paid on behalf of the Company. This note payable - related party earns interest at 8% per annum, is unsecured and is due on demand.
Our policy with regard to transactions with related persons or entities is that such transactions must be on terms no less favorable than could be obtained from non-related persons.
The above related party transactions are not necessarily indicative of the amounts that would have been incurred had a comparable transaction been entered into with an independent party. The terms of these transactions were more favorable than would have been attained if the transactions were negotiated at arm's length.
PROPOSED TRANSACTIONS
The Company is not anticipating any transactions.
CHANGES IN ACCOUNTING POLICIES INCLUDING INITIAL ADOPTION
Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on accounting policies.
FINANCIAL INSTRUMENTS
The main risks of the Company's financial instrument are exposed to are credit risk, market risk, foreign exchange risk, and liquidity risk.
Credit risk
The Company's credit risk is primarily attributable to trade receivables. Trade receivables comprise amounts due from other businesses from the sale of groceries and dry goods. The Company mitigates credit risk through approvals, limits and monitoring. The amounts disclosed in the consolidated balance sheet are net of allowances for expected credit losses, estimated by the Company's management based on past experience and specific circumstances of the customer. The Company manages credit risk for cash by placing deposits at major Canadian financial institutions.
Market risk
Market risk is the risk that changes in market prices and interest rates will affect the Company's net earnings or the value of financial instruments. These risks are generally outside the control of the Company. The objective of the Company is to mitigate market risk exposures within acceptable limits, while maximizing returns. The Company's market risk consists of risks from changes in foreign exchange rates, interest rates and market prices that affect its financial liabilities, financial assets and future transactions.
Refer to Note 2 in the consolidated financial statements for the year ended December 31, 2025 and Note 2 in the consolidated financial statements for the year ended December 31, 2025 for information on market risk.
Foreign Exchange risk
Our revenue is derived from operations in Canada. Our consolidated financial statements are presented in U.S. dollars and our liabilities other than trade payables are primarily due in U.S. dollars. The revenue we earn in Canadian dollars is adversely impacted by the increase in the value of the U.S. dollar relative to the Canadian dollar.
Liquidity risk
Liquidity risk relates to the risk the Company will encounter difficulty in meeting its obligations associated with financial liabilities. The financial liabilities on our consolidated balance sheets consist of accounts payable and accrued liabilities, due to related party, notes payable, convertible notes, net, derivative liabilities, promissory notes, promissory notes - related party and non-redeemable convertible notes, Management monitors cash flow requirements and future cash flow forecasts to ensure it has access to funds through its existing cash and from operations to meet operational and financial obligations
OUTSTANDING SHARE DATA
As of May 12, 2026, the following securities were outstanding:
Common stock 6,633,882,467 shares
OFF-BALANCE SHEET TRANSACTIONS
We currently have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.